Brief About Dr. Shyam Kishore Shrivastava
Dr. Shyam Kishore Shrivastava is a well-known radiation oncologist with more than 41 years of expertise. He is a member of a number of government and non-government organisations that work to improve radiation facilities and human resources around the world. He has over 280 peer-reviewed papers and book chapters to his credit, as well as over 95 research initiatives in the field of radiation oncology.
Clinical Interests
- Brachytherapy (Internal Radiation Therapy)
- External Beam Radiation For Prostate Cancer
- Cranial Cyber-Knife Radiosurgery
- Breast Cancer Management
- Image-Guided Radio Therapy (IGRT), etc.
Member of Associations
- National and international organizations including Maharashtra Medical Council (MMC)
- Association of Radiation Oncologist of India (AROI)
- Indian Medical Association (IMA)
- Indian Nuclear Society (INS)
- American Society for Therapeutic Radiology & Oncology (ASTRO)
- European Society for Therapeutic Radiology & Oncology (ESTRO)
- International Psycho-Oncology Society (IPOS)
- Federation of Asian Associations of Radiation Oncology (FARO)
- Association of Radiation Oncologists of India (AROI), etc.
His Awards
- Academic Excellence Oration (Professionalism for Oncology Profession) of Dr. B Barooah Cancer Institute, Guwahati, Assam,
- “Lifetime Achievement Award” Association of Radiation Oncologists’ of India MP&CG Chapter and MGM Medical College Indore
- “Dr. TB Patel Oration Award” at Gujarat Cancer & Research Institute (GCRI), Ahmedabad, etc.
Paper Published
- Concurrent Chemo-Radiotherapy vs Radiotherapy with a boost in locally advanced unresectable rectal Cancers. A randomized phase II study, 2013.
- Endobiliary stent marker for patient alignment in image-guided radiotherapy in pancreatic and periampullary cancers, 2013.
- Escalated radiation dose alone vs. concurrent chemoradiation for locally advanced and unresectable rectal cancers: results from phase II randomized study, 2013.
- Evaluation of interobserver and interscale agreement in assessing late bowel toxicity after pelvic radiation in patients with carcinoma of the cervix, 2013.
- Helical tomotherapy-based hypofractionated radiotherapy for prostate cancer: A report on the procedure, dosimetry and preliminary clinical outcome, 2013
 (1).png)